Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta (HPV)
Primary Purpose
Cervical Cancer
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Pap testing
Choice
Sponsored by
About this trial
This is an interventional screening trial for Cervical Cancer focused on measuring self-sampling for HPV testing
Eligibility Criteria
Inclusion Criteria:
- no personal history of cervical cancer
- not have engaged in cervical cancer screening in the past four years
Exclusion Criteria:
- none
Sites / Locations
- Mississippi State Department of Health
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Pap testing
Choice
Arm Description
Women assigned to this arm will be scheduled a Pap testing appointment at the local health department
Women assigned to this arm will be given a choice between scheduling an appointment for a Pap testing at the health department or engage in self-sampling for HPV testing at home
Outcomes
Primary Outcome Measures
adherence to cervical cancer screening
adherence to cerivcal cancer screening by attending the Pap testing or returning the self-collected sample for HPV testing
Secondary Outcome Measures
Satisfaction with the intervention
We will assess participants' satisfaction with intervention through self-report (satisfaction questionnaire - satisfied/very satisfied)
Full Information
NCT ID
NCT03713710
First Posted
October 18, 2018
Last Updated
November 15, 2022
Sponsor
University of Alabama at Birmingham
Collaborators
American Cancer Society, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT03713710
Brief Title
Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta
Acronym
HPV
Official Title
Self-Sampling for HPV Testing in African American Women - Mississippi Delta
Study Type
Interventional
2. Study Status
Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
November 28, 2016 (Actual)
Primary Completion Date
December 31, 2019 (Actual)
Study Completion Date
December 31, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Alabama at Birmingham
Collaborators
American Cancer Society, Inc.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to examine the efficacy and costs of this patient-centered approach ("Choice" between two cervical cancer screening modalities) in adherence to cervical cancer screening as compared to the current standard of care within the public health system in Mississippi (Pap test at the local department -"Pap") among un/under-screened African American women in the Mississippi Delta using a theory-based, culturally relevant intervention implemented by Peer Health Educators (PHEs).
Detailed Description
OBJECTIVE: Our objective is to examine the efficacy and costs of a patient-centered approach ("Choice" between self-sampling and Pap test) in adherence to cervical cancer screening as compared to Pap test at the local health department ("Pap") among un/under-screened African American women in the Mississippi Delta.
HYPOTHESES: Women in the "Choice" arm will have a higher cervical cancer screening adherence as well as higher satisfaction than women assigned to the "Pap" arm; (2) Within the "Choice" arm, more women will choose and complete self-sampling than Pap test; and (3) The "Choice" intervention will be on average less costly and more cost-effective than the "Pap" intervention.
SPECIFIC AIMS: (1) To compare the impact of these two intervention approaches, "Choice" versus "Pap", on cervical cancer screening adherence through a group randomized controlled trial; (2) To compare patient satisfaction between the two intervention approaches; and (3) To compare the costs and cost-effectiveness of these two intervention approaches, "Choice" versus "Pap".
STUDY DESIGN: 12 towns will be randomized to either "Choice" or "Pap" (180 women/arm). Peer Health Educators (PHEs) will identify African American women who report not having undergone cervical cancer screening in the past three years and deliver a brief theory-based, cultural relevant educational session on cervical cancer and screening using a door-to-door approach. Women randomized to the "Pap" arm will be provided with information on how to schedule an appointment at the local health department. Women randomized to the "Choice" arm will be given the choice of attending the health department for a Pap test or self-collecting their own sample at home to be sent for HPV testing. PHEs will follow-up with women in either arm who have a positive test in order to assure diagnostic evaluation and care.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Cancer
Keywords
self-sampling for HPV testing
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
335 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Pap testing
Arm Type
Experimental
Arm Description
Women assigned to this arm will be scheduled a Pap testing appointment at the local health department
Arm Title
Choice
Arm Type
Experimental
Arm Description
Women assigned to this arm will be given a choice between scheduling an appointment for a Pap testing at the health department or engage in self-sampling for HPV testing at home
Intervention Type
Behavioral
Intervention Name(s)
Pap testing
Intervention Description
Women will be approached in the community by a Peer Health Educator and scheduled an appointment for a Pap testing at the local health department
Intervention Type
Behavioral
Intervention Name(s)
Choice
Intervention Description
Women will be approached in the community by a Peer Health Educator and they will be given a choice between scheduling an appointment for a Pap testing at the local health department or engage in self-sampling for HPV testing at home
Primary Outcome Measure Information:
Title
adherence to cervical cancer screening
Description
adherence to cerivcal cancer screening by attending the Pap testing or returning the self-collected sample for HPV testing
Time Frame
baseline to 30 days
Secondary Outcome Measure Information:
Title
Satisfaction with the intervention
Description
We will assess participants' satisfaction with intervention through self-report (satisfaction questionnaire - satisfied/very satisfied)
Time Frame
baseline to 6 months
10. Eligibility
Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
no personal history of cervical cancer
not have engaged in cervical cancer screening in the past four years
Exclusion Criteria:
none
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Isabel C. Scarinci, PhD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mississippi State Department of Health
City
Jackson
State/Province
Mississippi
ZIP/Postal Code
39211
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
33338505
Citation
Scarinci IC, Li Y, Tucker L, Campos NG, Kim JJ, Peral S, Castle PE. Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial. Prev Med. 2021 Jan;142:106358. doi: 10.1016/j.ypmed.2020.106358. Epub 2020 Dec 16.
Results Reference
derived
Learn more about this trial
Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta
We'll reach out to this number within 24 hrs